CJC-1295 & Ipamorelin

CJC-1295 and Ipamorelin are synthetic research peptides studied for their coordinated interaction with growth hormone–associated signaling pathways. CJC-1295 is a growth hormone–releasing hormone (GHRH) analog that binds GHRH receptors, while Ipamorelin functions as a selective growth hormone secretagogue through ghrelin receptor (GHS-R1a) activation. Preclinical research utilizes this peptide combination to investigate receptor binding kinetics, somatotropic axis modulation, and synergistic endocrine signaling mechanisms under controlled laboratory conditions.

For research use only. Not for human consumption.